Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Harvard Medical School, Department of Global Health and Social Medicine, USA.
Vaccine. 2024 Oct 3;42(23):126196. doi: 10.1016/j.vaccine.2024.126196. Epub 2024 Aug 22.
Adverse events following immunization (AEFIs), especially if serious, may impact vaccine recipients' quality of life and financial well-being and fuel vaccine hesitancy. Nigeria rolled out COVID-19 vaccination in 2021 with little known about the impact of AEFIs on an individual's quality of life. No study in Africa has explored the health and financial impact of AEFIs. We explored patient-reported outcomes (PROs) of adverse events after COVID-19 vaccination and documented the lived experiences of those with serious AEFIs to understand the effect on their health, financial well-being, and attitude to future vaccinations.
We conducted a convergent mixed-methods study using the RAND 36-item health survey and in-depth interviews to collect PROs on vaccine recipients in Nigeria. Eight health scale scores and two summary composite scores were used to measure the health-related quality of life outcomes from the survey and inductive analysis was used to identify themes from the interview scripts. The results of both studies were integrated in a joint display to highlight areas of concordance.
In total, 785 survey responses were analyzed (53% females, 68% aged 18-30 years). Responders reporting an AEFI were 58%, of whom 62% received the first dose only. Younger age and first vaccine dose (p < .001 respectively) were associated with experiencing an AEFI. Not reporting an AEFI was associated with better quality of life, measured as higher scores on all eight SF-36 Health scales and the physical and mental component summary scores. All six interviewees with serious AEFIs experienced physical, mental, and financial distress. Some expressed a strong negative attitude toward future COVID-19 vaccinations but not toward vaccines for routine immunization.
AEFIs negatively impact the health and financial well-being of affected individuals and their attitude to future vaccinations, especially if serious. Understanding the impact of AEFIs on people is important and should inform future policies and interventions. The results of our study can inform policy and planning for future mass vaccination campaigns in LMICs.
疫苗接种后不良反应(AEFI),尤其是严重的不良反应,可能会影响疫苗接种者的生活质量和经济状况,并导致疫苗犹豫。尼日利亚于 2021 年推出了 COVID-19 疫苗接种,但对 AEFI 对个人生活质量的影响知之甚少。非洲尚无研究探讨 AEFI 对健康和经济的影响。我们探讨了 COVID-19 疫苗接种后不良事件的患者报告结局(PRO),并记录了严重 AEFI 患者的生活经历,以了解其对健康、经济福祉和对未来疫苗接种态度的影响。
我们采用 RAND 36 项健康调查和深入访谈的收敛混合方法研究,收集尼日利亚疫苗接种者的 PRO。使用八项健康量表评分和两项综合评分来衡量调查的健康相关生活质量结果,并采用归纳分析从访谈脚本中识别主题。两项研究的结果在联合展示中整合,以突出一致性领域。
共分析了 785 份调查回复(53%为女性,68%年龄在 18-30 岁)。报告发生 AEFI 的应答者占 58%,其中 62%仅接种了第一剂疫苗。年龄较小和接种第一剂疫苗(分别为 p<0.001)与发生 AEFI 相关。未报告 AEFI 与生活质量更高相关,表现在所有八项 SF-36 健康量表和身体和精神成分综合评分上的得分更高。所有 6 名有严重 AEFI 的受访者均经历了身体、心理和经济困扰。一些人对未来 COVID-19 疫苗接种持强烈的负面态度,但对常规免疫接种疫苗则没有。
AEFI 会对受影响个人的健康和经济状况及其对未来疫苗接种的态度产生负面影响,尤其是严重的 AEFI。了解 AEFI 对人们的影响很重要,应指导未来的政策和干预措施。我们的研究结果可为中低收入国家未来的大规模疫苗接种运动提供政策和规划信息。